Anne Michelle Clem Whitaker's most recent trade in Orasure Technologies Inc. was a trade of 4,400 Common Stock done at an average price of $5.6 . Disclosure was reported to the exchange on May 15, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Orasure Technologies Inc. | Anne Michelle Clem Whitaker | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.62 per share. | 15 May 2023 | 4,400 | 26,163 (0%) | 0% | 5.6 | 24,706 | Common Stock |
Orasure Technologies Inc. | Anne Michelle Clem Whitaker | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.30 per share. | 15 May 2023 | 2,323 | 23,840 (0%) | 0% | 5.3 | 12,318 | Common Stock |
Orasure Technologies Inc. | Anne Michelle Clem Whitaker | Director | Grant, award, or other acquisition of securities at price $ 5.25 per share. | 16 May 2022 | 20,000 | 30,563 (0%) | 0% | 5.3 | 105,000 | Common Stock |
Lisata Therapeutics Inc | Anne Michelle Clem Whitaker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2022 | 65,430 | 182,635 (1%) | 0% | 0 | Common Stock | |
Orasure Technologies Inc. | Anne Michelle Clem Whitaker | Director | Grant, award, or other acquisition of securities at price $ 9.94 per share. | 08 Nov 2021 | 10,563 | 10,563 (0%) | 0% | 9.9 | 104,996 | Common Stock |
Lisata Therapeutics Inc | Anne Michelle Clem Whitaker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2021 | 37,735 | 117,205 (1%) | 0% | 0 | Common Stock |